Posters on the topic "Neurodegeneration self study"

Back
Progressive supranuclear palsy subtypes in a neuropathology cohort
  • Anne Sieben (Antwerp, BE)
  • eP-ND-A188
Kallikrein-8 cleaves APOE4, but not APOE2 and thereby affects Alzheimer's pathology
  • eP-ND-A189
Dysregulation of the Kallikrein-kinin-system in Alzheimer's Disease is mediated by Kallikrein-8
  • eP-ND-A190
Heterogeneity of medullary pathology in Multiple System Atrophy
  • eP-ND-A191
Microglial LRRK2-mediated NFATc1 attenuates α-Synuclein immunotoxicity in association with CX3CR1-induced migration and the lysosome-initiated degradation
  • eP-ND-A192
N- and O-linked sialylation in Alzheimer's Disease postmortem brain tissue
  • eP-ND-A194
Clinicopathological features of progressive supranuclear palsy with asymmetrical atrophy of the superior cerebellar peduncle
  • eP-ND-A195
Novel quantitative digital pathology pipeline to map regional misfolded protein pathology in Parkinson's Disease
  • eP-ND-A196
Intranasal administration of trehalose reduces α-synuclein oligomers by accelerating aggregate formation in a mouse model of multiple system atrophy
  • eP-ND-A197
Clinical and pathologic spectrum of neurodegeneration with TDP-43(+) inclusions – ALS, PLS and semantic variant of primary progressive aphasia
  • eP-ND-A198
Clinicopathological characterization and concomitant proteinopathies in ALS patients
  • eP-ND-A200
Validation of spatial transcriptomics approaches on post-mortem brain tissue from patients with Lewy body disorders
  • eP-ND-A201
Salivary alpha-synuclein as a potential diagnostic marker of Parkinson's Disease
  • eP-ND-A202
Clinicopathological spectrum of globular glial tauopathies (GGT)
  • eP-ND-A204
A new case of Mitochondrial Membrane Protein Associated Neurodegeneration (MPAN)
  • eP-ND-A206
Honey and black seed synergistically promote regeneration of oligodendrocytes in cuprizone intoxicated quail brain
  • eP-ND-A207
Severe argyrophilic grain disease in a centenarian with severe dementia who did not show the "sloping shoulders sign"
  • eP-ND-A209
Demyelination triggers divergent neuropathological consequences in APPSWE and APPSWE/PSEN1dE9 transgenic mouse models of Alzheimer's Disease
  • eP-ND-A210
Progressive supranuclear palsy presenting with late onset chorea plus ataxia syndrome – a rare phenotype with severe oligodendrocytic involvement and globular morphologies
  • eP-ND-A211
CCP1, a regulator of tubulin post-translational modifications, potentially plays an essential role in cerebellar development
  • eP-ND-A212
Evaluation of disease-specific α-synuclein seeding in formaldehyde-fixed paraffin-embedded human brain archived long-term
  • eP-ND-A213
Multi-centric plaques in kuru
  • eP-ND-A215
Multiple system atrophy with abundant nigral neuronal cytoplasmic inclusions presenting slowly progressive levodopa-responsive Parkinsonism
  • eP-ND-A216
Significant contralaterality of temporal-predominant neuro-astroglial tau pathologies and FTLD-TDP type C presenting with the right temporal variant FTD
  • eP-ND-A218
Mixed brain pathology in neurodegenerative parkinsonism and dementia
  • eP-ND-A219
Altered iron content in superficial and deep white matter in Alzheimer's Disease
  • eP-ND-A221
Histological methods to study spinal receptor expression after degeneration of descending tracts
  • eP-ND-A223
Molecular subtyping of Progressive Supranuclear Palsy – a proof of concept
  • eP-ND-A224
Alpha-synuclein inclusions in the dentate gyrus are associated with cognitive impairment in multiple system atrophy
  • eP-ND-A225
Beta-amyloid is only seen in the extracellular compartment in diagnostic brain biopsies from idiopathic normal pressure hydrocephalus patients
  • PS3-ND-A165
Pathologic subtyping of Alzheimer's Disease brain tissue reveals disease heterogeneity
  • PS3-ND-A166
Understanding the role of extracellular vesicles in the pathophysiology of Alzheimer's Disease
  • PS3-ND-A167
The role of CD22 in Alzheimer's Disease pathology in APPPS1 mice
  • PS3-ND-A168
Interleukin-12-driven crosstalk in Alzheimer's Disease affecting oligodendrocyte survival and myelination
  • PS3-ND-A169
Extra densities in cryo-EM maps of fibrils from Alzheimer's Disease and other neurodegenerations
  • PS3-ND-A170
The neuropathological landscape of Hispanic and Non-Hispanic White Decedents with Alzheimer's Disease
  • PS3-ND-A171
The interaction between Kallikrein-8 and its inhibitory network affects Alzheimer's Disease
  • PS8-ND-A173
MAPT mutation ΔK281 causes genetically determined pick disease
  • PS8-ND-A174
The LifeAfter90 Study – 2023 report on the neuropathology of an ethnically diverse cohort study of oldest-old in the United States
  • PS8-ND-A175
Inconsistent cytopathological distinction between astrocytic plaques and tuft-shaped astrocytes along their morphological spectrum – a neuropathology based inter-rater study
  • PS8-ND-A176
Autopsy case of corticobasal degeneration with 3-repeat tau accumulation in the precentral gyrus, basal ganglia, substantia nigra and locus coeruleus
  • PS8-ND-A177
Tau pathology in limbic predominant neuronal inclusion body disease – a new 4R Tauopathy
  • PS8-ND-A178
Cell-specific MAPT gene expression is preserved in neuronal and glial tau cytopathologies in Progressive Supranuclear Palsy
  • PS8-ND-A179
TDP-43 forms amyloid filaments with a distinct fold in the brains of GRN mutation carriers
  • PS9-ND-A180
NOTCH2NLC GGC repeat expansion causes retinal pathology of NIID patients
  • PS9-ND-A181
Alpha-Synuclein pathology in the enteric nervous system is a potential biomarker for Parkinson's Disease
  • PS9-ND-A182
Relation between clinical findings and progression of cerebral cortical pathology in sporadic Creutzfeldt-Jakob disease
  • PS9-ND-A183
Regional variability of α-synuclein inclusion size in multiple system atrophy
  • PS9-ND-A184
Impaired synaptic gene expression networks in patients with alpha-Synuclein and tau co-pathology
  • PS9-ND-A185
Original histological phenotype after the experimental transmission to primate of an unsusual human prionopathy (VPSPr)
  • PS9-ND-A186
Dynamic change of synuclein transcription during Lewy body formation
  • PS9-ND-A187
Qualitative and quantitative alterations of synaptotagmin 13 in synucleinopathies
  • S14-ND-A159
Consistent and distinct involvement of the cranial and spinal nerves in PSP and other tauopathies
  • S14-ND-A160
DNA methylation differences in Alzheimer's Disease neuropathology in old age – a comprehensive brain region survey
  • S14-ND-A161
Blood CNS regionally enriched extracellular vesicles carrying pTau217 for Alzheimer's Disease diagnosis and differential diagnosis
  • S14-ND-A162
Investigating ALS pathogenesis caused by distinct SOD1 strains in transgenic mouse models
  • S14-ND-A163
Alterations of neuroprotective ER- co-chaperone SIL1 – disruption of autophagy and RNA binding protein homeostasis and selective neuronal vulnerability in Amyotrophic lateral sclerosis (ALS)